CTI BioPharma
CTIC
#5622
Rank
A$1.81 B
Marketcap
A$13.76
Share price
0.00%
Change (1 day)
27.69%
Change (1 year)

CTI BioPharma (CTIC) - Total assets

Total assets on the balance sheet as of March 2023 : A$0.16 Billion

According to CTI BioPharma 's latest financial reports the company's total assets are A$0.16 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

CTI BioPharma - Total assets on balance sheet (from 2001 to 2023)

Total assets by year

Year Total assets Change
2022-12-31A$0.18 B85.21%
2021-12-31A$99.91 M31.91%
2020-12-31A$75.74 M14.59%
2019-12-31A$66.1 M-48.16%
2018-12-31A$0.12 B81.38%
2017-12-31A$70.3 M-20.62%
2016-12-31A$88.56 M-55.3%
2015-12-31A$0.19 B75.7%
2014-12-31A$0.11 B7.32%
2013-12-31A$0.10 B48.13%
2012-12-31A$70.93 M16.86%
2011-12-31A$60.7 M15.05%
2010-12-31A$52.75 M-31.9%
2009-12-31A$77.47 M-14.92%
2008-12-31A$91.05 M8.29%
2007-12-31A$84.08 M-34.9%
2006-12-31A$0.12 B-39.2%
2005-12-31A$0.21 B-11.14%
2004-12-31A$0.23 B21.63%
2003-12-31A$0.19 B-40.72%
2002-12-31A$0.33 B-44.3%
2001-12-31A$0.59 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
A$136.44 B 80,188.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$146.65 B 86,198.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
A$9.58 B 5,538.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$31.88 B 18,664.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$173.97 B 102,271.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$60.32 B 35,399.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
A$162.40 B 95,461.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland